🇺🇸 Convalescent Plasma in United States

591 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 272 reports (46.02%)
  2. Drug Ineffective For Unapproved Indication — 76 reports (12.86%)
  3. Drug Ineffective — 45 reports (7.61%)
  4. Covid-19 — 43 reports (7.28%)
  5. Respiratory Failure — 42 reports (7.11%)
  6. Maternal Exposure During Pregnancy — 25 reports (4.23%)
  7. Acute Kidney Injury — 23 reports (3.89%)
  8. Covid-19 Pneumonia — 22 reports (3.72%)
  9. Death — 22 reports (3.72%)
  10. Alanine Aminotransferase Increased — 21 reports (3.55%)

Source database →

Frequently asked questions

Is Convalescent Plasma approved in United States?

Convalescent Plasma does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Convalescent Plasma in United States?

Hackensack Meridian Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.